Peer Review reports
From: Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis
| Original Submission | ||
|---|---|---|
| 20 Oct 2022 | Submitted | Original manuscript |
| 25 Oct 2022 | Author responded | Author comments - Dongchang Wang |
| 12 Dec 2022 | Reviewed | Reviewer Report - Abdul S. Ethayathulla |
| 13 Dec 2022 | Reviewed | Reviewer Report |
| 22 Jan 2023 | Reviewed | Reviewer Report - Ning Li |
| 21 Feb 2023 | Author responded | Author comments - Dongchang Wang |
| Resubmission - Version 2 | ||
| 25 Oct 2022 | Submitted | Manuscript version 2 |
| 2 Mar 2023 | Author responded | Author comments - Dongchang Wang |
| Resubmission - Version 3 | ||
| 2 Mar 2023 | Submitted | Manuscript version 3 |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 9 Mar 2023 | Author responded | Author comments - Dongchang Wang |
| Resubmission - Version 5 | ||
| 9 Mar 2023 | Submitted | Manuscript version 5 |
| 22 Mar 2023 | Reviewed | Reviewer Report - Ning Li |
| 25 Mar 2023 | Reviewed | Reviewer Report - Abdul S. Ethayathulla |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 2 Apr 2023 | Editorially accepted | |
| 18 Apr 2023 | Article published | 10.1186/s12859-023-05268-2 |
You can find further information about peer review here.